Cargando…

The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study

OBJECTIVE: To study the association between dietary flavonoid and lignan intakes, and the risk of development of type 2 diabetes among European populations. RESEARCH DESIGN AND METHODS: The European Prospective Investigation into Cancer and Nutrition-InterAct case-cohort study included 12,403 incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamora-Ros, Raul, Forouhi, Nita G., Sharp, Stephen J., González, Carlos A., Buijsse, Brian, Guevara, Marcela, van der Schouw, Yvonne T., Amiano, Pilar, Boeing, Heiner, Bredsdorff, Lea, Clavel-Chapelon, Françoise, Fagherazzi, Guy, Feskens, Edith J., Franks, Paul W., Grioni, Sara, Katzke, Verena, Key, Timothy J., Khaw, Kay-Tee, Kühn, Tilman, Masala, Giovanna, Mattiello, Amalia, Molina-Montes, Esther, Nilsson, Peter M., Overvad, Kim, Perquier, Florence, Quirós, J. Ramón, Romieu, Isabelle, Sacerdote, Carlotta, Scalbert, Augustin, Schulze, Matthias, Slimani, Nadia, Spijkerman, Annemieke M.W., Tjonneland, Anne, Tormo, Maria Jose, Tumino, Rosario, van der A, Daphne L., Langenberg, Claudia, Riboli, Elio, Wareham, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836159/
https://www.ncbi.nlm.nih.gov/pubmed/24130345
http://dx.doi.org/10.2337/dc13-0877
_version_ 1782292279629709312
author Zamora-Ros, Raul
Forouhi, Nita G.
Sharp, Stephen J.
González, Carlos A.
Buijsse, Brian
Guevara, Marcela
van der Schouw, Yvonne T.
Amiano, Pilar
Boeing, Heiner
Bredsdorff, Lea
Clavel-Chapelon, Françoise
Fagherazzi, Guy
Feskens, Edith J.
Franks, Paul W.
Grioni, Sara
Katzke, Verena
Key, Timothy J.
Khaw, Kay-Tee
Kühn, Tilman
Masala, Giovanna
Mattiello, Amalia
Molina-Montes, Esther
Nilsson, Peter M.
Overvad, Kim
Perquier, Florence
Quirós, J. Ramón
Romieu, Isabelle
Sacerdote, Carlotta
Scalbert, Augustin
Schulze, Matthias
Slimani, Nadia
Spijkerman, Annemieke M.W.
Tjonneland, Anne
Tormo, Maria Jose
Tumino, Rosario
van der A, Daphne L.
Langenberg, Claudia
Riboli, Elio
Wareham, Nicholas J.
author_facet Zamora-Ros, Raul
Forouhi, Nita G.
Sharp, Stephen J.
González, Carlos A.
Buijsse, Brian
Guevara, Marcela
van der Schouw, Yvonne T.
Amiano, Pilar
Boeing, Heiner
Bredsdorff, Lea
Clavel-Chapelon, Françoise
Fagherazzi, Guy
Feskens, Edith J.
Franks, Paul W.
Grioni, Sara
Katzke, Verena
Key, Timothy J.
Khaw, Kay-Tee
Kühn, Tilman
Masala, Giovanna
Mattiello, Amalia
Molina-Montes, Esther
Nilsson, Peter M.
Overvad, Kim
Perquier, Florence
Quirós, J. Ramón
Romieu, Isabelle
Sacerdote, Carlotta
Scalbert, Augustin
Schulze, Matthias
Slimani, Nadia
Spijkerman, Annemieke M.W.
Tjonneland, Anne
Tormo, Maria Jose
Tumino, Rosario
van der A, Daphne L.
Langenberg, Claudia
Riboli, Elio
Wareham, Nicholas J.
author_sort Zamora-Ros, Raul
collection PubMed
description OBJECTIVE: To study the association between dietary flavonoid and lignan intakes, and the risk of development of type 2 diabetes among European populations. RESEARCH DESIGN AND METHODS: The European Prospective Investigation into Cancer and Nutrition-InterAct case-cohort study included 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 participants from among 340,234 participants with 3.99 million person-years of follow-up in eight European countries. At baseline, country-specific validated dietary questionnaires were used. A flavonoid and lignan food composition database was developed from the Phenol-Explorer, the U.K. Food Standards Agency, and the U.S. Department of Agriculture databases. Hazard ratios (HRs) from country-specific Prentice-weighted Cox regression models were pooled using random-effects meta-analysis. RESULTS: In multivariable models, a trend for an inverse association between total flavonoid intake and type 2 diabetes was observed (HR for the highest vs. the lowest quintile, 0.90 [95% CI 0.77–1.04]; P valuetrend = 0.040), but not with lignans (HR 0.88 [95% CI 0.72–1.07]; P valuetrend = 0.119). Among flavonoid subclasses, flavonols (HR 0.81 [95% CI 0.69–0.95]; P valuetrend = 0.020) and flavanols (HR 0.82 [95% CI 0.68–0.99]; P valuetrend = 0.012), including flavan-3-ol monomers (HR 0.73 [95% CI 0.57–0.93]; P valuetrend = 0.029), were associated with a significantly reduced hazard of diabetes. CONCLUSIONS: Prospective findings in this large European cohort demonstrate inverse associations between flavonoids, particularly flavanols and flavonols, and incident type 2 diabetes. This suggests a potential protective role of eating a diet rich in flavonoids, a dietary pattern based on plant-based foods, in the prevention of type 2 diabetes.
format Online
Article
Text
id pubmed-3836159
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38361592014-12-01 The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study Zamora-Ros, Raul Forouhi, Nita G. Sharp, Stephen J. González, Carlos A. Buijsse, Brian Guevara, Marcela van der Schouw, Yvonne T. Amiano, Pilar Boeing, Heiner Bredsdorff, Lea Clavel-Chapelon, Françoise Fagherazzi, Guy Feskens, Edith J. Franks, Paul W. Grioni, Sara Katzke, Verena Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Masala, Giovanna Mattiello, Amalia Molina-Montes, Esther Nilsson, Peter M. Overvad, Kim Perquier, Florence Quirós, J. Ramón Romieu, Isabelle Sacerdote, Carlotta Scalbert, Augustin Schulze, Matthias Slimani, Nadia Spijkerman, Annemieke M.W. Tjonneland, Anne Tormo, Maria Jose Tumino, Rosario van der A, Daphne L. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. Diabetes Care Original Research OBJECTIVE: To study the association between dietary flavonoid and lignan intakes, and the risk of development of type 2 diabetes among European populations. RESEARCH DESIGN AND METHODS: The European Prospective Investigation into Cancer and Nutrition-InterAct case-cohort study included 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 participants from among 340,234 participants with 3.99 million person-years of follow-up in eight European countries. At baseline, country-specific validated dietary questionnaires were used. A flavonoid and lignan food composition database was developed from the Phenol-Explorer, the U.K. Food Standards Agency, and the U.S. Department of Agriculture databases. Hazard ratios (HRs) from country-specific Prentice-weighted Cox regression models were pooled using random-effects meta-analysis. RESULTS: In multivariable models, a trend for an inverse association between total flavonoid intake and type 2 diabetes was observed (HR for the highest vs. the lowest quintile, 0.90 [95% CI 0.77–1.04]; P valuetrend = 0.040), but not with lignans (HR 0.88 [95% CI 0.72–1.07]; P valuetrend = 0.119). Among flavonoid subclasses, flavonols (HR 0.81 [95% CI 0.69–0.95]; P valuetrend = 0.020) and flavanols (HR 0.82 [95% CI 0.68–0.99]; P valuetrend = 0.012), including flavan-3-ol monomers (HR 0.73 [95% CI 0.57–0.93]; P valuetrend = 0.029), were associated with a significantly reduced hazard of diabetes. CONCLUSIONS: Prospective findings in this large European cohort demonstrate inverse associations between flavonoids, particularly flavanols and flavonols, and incident type 2 diabetes. This suggests a potential protective role of eating a diet rich in flavonoids, a dietary pattern based on plant-based foods, in the prevention of type 2 diabetes. American Diabetes Association 2013-12 2013-11-13 /pmc/articles/PMC3836159/ /pubmed/24130345 http://dx.doi.org/10.2337/dc13-0877 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Zamora-Ros, Raul
Forouhi, Nita G.
Sharp, Stephen J.
González, Carlos A.
Buijsse, Brian
Guevara, Marcela
van der Schouw, Yvonne T.
Amiano, Pilar
Boeing, Heiner
Bredsdorff, Lea
Clavel-Chapelon, Françoise
Fagherazzi, Guy
Feskens, Edith J.
Franks, Paul W.
Grioni, Sara
Katzke, Verena
Key, Timothy J.
Khaw, Kay-Tee
Kühn, Tilman
Masala, Giovanna
Mattiello, Amalia
Molina-Montes, Esther
Nilsson, Peter M.
Overvad, Kim
Perquier, Florence
Quirós, J. Ramón
Romieu, Isabelle
Sacerdote, Carlotta
Scalbert, Augustin
Schulze, Matthias
Slimani, Nadia
Spijkerman, Annemieke M.W.
Tjonneland, Anne
Tormo, Maria Jose
Tumino, Rosario
van der A, Daphne L.
Langenberg, Claudia
Riboli, Elio
Wareham, Nicholas J.
The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
title The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
title_full The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
title_fullStr The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
title_full_unstemmed The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
title_short The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
title_sort association between dietary flavonoid and lignan intakes and incident type 2 diabetes in european populations: the epic-interact study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836159/
https://www.ncbi.nlm.nih.gov/pubmed/24130345
http://dx.doi.org/10.2337/dc13-0877
work_keys_str_mv AT zamorarosraul theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT forouhinitag theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT sharpstephenj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT gonzalezcarlosa theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT buijssebrian theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT guevaramarcela theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT vanderschouwyvonnet theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT amianopilar theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT boeingheiner theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT bredsdorfflea theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT clavelchapelonfrancoise theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT fagherazziguy theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT feskensedithj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT frankspaulw theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT grionisara theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT katzkeverena theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT keytimothyj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT khawkaytee theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT kuhntilman theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT masalagiovanna theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT mattielloamalia theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT molinamontesesther theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT nilssonpeterm theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT overvadkim theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT perquierflorence theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT quirosjramon theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT romieuisabelle theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT sacerdotecarlotta theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT scalbertaugustin theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT schulzematthias theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT slimaninadia theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT spijkermanannemiekemw theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT tjonnelandanne theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT tormomariajose theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT tuminorosario theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT vanderadaphnel theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT langenbergclaudia theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT ribolielio theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT warehamnicholasj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT zamorarosraul associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT forouhinitag associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT sharpstephenj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT gonzalezcarlosa associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT buijssebrian associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT guevaramarcela associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT vanderschouwyvonnet associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT amianopilar associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT boeingheiner associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT bredsdorfflea associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT clavelchapelonfrancoise associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT fagherazziguy associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT feskensedithj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT frankspaulw associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT grionisara associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT katzkeverena associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT keytimothyj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT khawkaytee associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT kuhntilman associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT masalagiovanna associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT mattielloamalia associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT molinamontesesther associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT nilssonpeterm associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT overvadkim associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT perquierflorence associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT quirosjramon associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT romieuisabelle associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT sacerdotecarlotta associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT scalbertaugustin associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT schulzematthias associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT slimaninadia associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT spijkermanannemiekemw associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT tjonnelandanne associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT tormomariajose associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT tuminorosario associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT vanderadaphnel associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT langenbergclaudia associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT ribolielio associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy
AT warehamnicholasj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy